The 9 analysts offering 12-month price forecasts for Stoke Therapeutics Inc have a median target of 50.00, with a high estimate of 83.00 and a low estimate of 24.00. The median estimate represents a +289.71% increase from the last price of 12.83.
The current consensus among 10 polled investment analysts is to Buy stock in Stoke Therapeutics Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.69
Reporting Date Nov 16
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.